GlassScriptPhysician profile
Ashok P Makadia
NPI 1013912211
$5,848.03
in general payments reported to CMS, 2019-2025
39 companies · $348 in 2025
The $348 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,845 · 2020: $976 · 2021: $642 · 2022: $953 · 2023: $921 · 2024: $162 · 2025: $348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,432.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,431.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,317.31 | 2019-2023 | Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals LP | $779.81 | 2019-2023 | Fasenra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $705.81 | 2019-2023 | Spiriva Respimat, Ofev, Stiolto Respimat |
| Actelion Pharmaceuticals US, INC. | $345.39 | 2019-2023 | Opsumit |
| Grifols USA, LLC | $250.37 | 2019-2025 | Prolastin-C Liquid |
| Astellas Pharma US INC | $218.40 | 2019-2022 | |
| Inspire Medical Systems, INC. | $205.14 | 2023-2024 | Inspire |
| Sunovion Pharmaceuticals INC. | $186.11 | 2019 | |
| Genzyme Corporation | $167.50 | 2019-2023 | |
| Circassia INC. | $138.54 | 2019-2020 | |
| Baxter Healthcare | $134.66 | 2022-2023 | Hillrom - Vest System Model 105 Home Care |
| Mylan Specialty L.P. | $127.14 | 2019-2023 | Yupelri |
| Teva Pharmaceuticals USA, INC. | $117.63 | 2020-2023 | Airduo Digihaler |
| Verona Pharma, INC. | $107.95 | 2025 | Ohtuvayre |
| Lilly USA, LLC | $107.41 | 2025 | Zepbound |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $93.04 | 2022-2023 | Dupixent |
| Bayer Healthcare Pharmaceuticals INC. | $81.31 | 2019-2023 | |
| Electromed, INC. | $72.77 | 2019 | |
| Harmony Biosciences LLC | $72.09 | 2022-2023 | Wakix |
| Advanced Respiratory, INC | $62.11 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $60.34 | 2020 | |
| Genentech USA, INC. | $57.35 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $45.01 | 2019-2020 | |
| Amgen INC. | $43.43 | 2022 | |
| Shire North American Group INC | $40.84 | 2019 | |
| Janssen Pharmaceuticals, INC | $37.89 | 2020 | |
| Jazz Pharmaceuticals INC. | $33.13 | 2019-2021 | |
| Inari Medical, INC. | $31.49 | 2020 | |
| Coloplast Corp | $30.18 | 2019 | |
| Axsome Therapeutics, INC. | $23.02 | 2023 | Sunosi |
| Sirtex Medical INC | $22.02 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.50 | 2024 | Lifevest |
| Cook Medical LLC | $19.40 | 2021 | |
| Sanofi-Aventis U.S. LLC | $17.77 | 2020 | |
| Philips North America LLC | $16.82 | 2020 | |
| Nabriva Therapeutics, Plc | $15.39 | 2020 | |
| Mallinckrodt Hospital Products INC. | $14.99 | 2021 | |
| Resmed Corp | $14.28 | 2019 | |
| Insmed, INC. | $13.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashok Makadia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.